Browsing Tag
Drug Discovery
3 posts
Drug discovery technology, AI-assisted research, molecular design, lab automation, and pharmaceutical R&D workflows.
GPT-6 Rosalind Costs $15/$75 and Remains Locked to Approved Labs
OpenAI's GPT-6 Rosalind brings Astra reasoning to life-sciences research at $15/$75 per million tokens. Here is what changed, who can use it and why human review remains mandatory.
Claude Science Turns Research AI Into a Lab Workflow Layer
Anthropic’s Claude Science beta gives researchers an AI workbench for literature review, code, compute jobs, scientific figures, and lab-specific agents. The launch matters because it treats AI for science less like a single model race and more like a workflow layer that has to connect databases, HPC systems, NVIDIA BioNeMo tools, and reproducible artifacts.
OpenAI’s AI Chemist Finds a Lab-Tested Way to Improve Drug Discovery Chemistry
OpenAI and Molecule.one connected GPT-5.4 to an autonomous chemistry platform that ran 10,080 reactions and found a TEMPO-based way to improve a difficult Chan-Lam coupling used in medicinal chemistry. The result is narrow, but it shows AI starting to work inside the experimental loop, not just around it.